{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T17:02:29Z","timestamp":1775581349989,"version":"3.50.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"High-Level Scientific Research Start-up Fund of the First Affiliated Hospital of Chengdu Medical College","award":["CYFY-GQ77"],"award-info":[{"award-number":["CYFY-GQ77"]}]},{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","award":["2026NSFSC1849"],"award-info":[{"award-number":["2026NSFSC1849"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Health Commission of Sichuan Province Medical Science and Technology Program","award":["25LCYJ52"],"award-info":[{"award-number":["25LCYJ52"]}]},{"name":"8th Chengdu Pharmaceutical Association Pharmaceutical Research Project","award":["Cdyxky8004"],"award-info":[{"award-number":["Cdyxky8004"]}]},{"name":"Youth Innovation Team Development Program for Higher Education Institutions in Shandong Province","award":["2024KJ037"],"award-info":[{"award-number":["2024KJ037"]}]},{"name":"Project of Scientific Research and Innovation Programme of Shandong Second Medical University","award":["2024BKQ040"],"award-info":[{"award-number":["2024BKQ040"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"DOI":"10.1007\/s10753-026-02489-4","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T09:59:14Z","timestamp":1774519154000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ethyl Gallate Ameliorates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease by Suppressing Inflammation and Modulating the Gut Microbiota-Intestinal Barrier Axis"],"prefix":"10.1007","volume":"49","author":[{"given":"Cheng","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Congyang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingkun","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chundi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changgang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"issue":"1","key":"2489_CR1","doi-asserted-by":"publisher","first-page":"100485","DOI":"10.1016\/j.jlr.2023.100485","volume":"65","author":"ME Rinella","year":"2024","unstructured":"Rinella, M. E., and S. Sookoian. 2024. From NAFLD to MASLD: updated naming and diagnosis criteria for fatty liver disease. Journal Of Lipid Research 65(1):100485.","journal-title":"Journal Of Lipid Research"},{"issue":"2","key":"2489_CR2","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1016\/j.jhep.2023.07.031","volume":"80","author":"A De","year":"2024","unstructured":"De, A., N. Bhagat, M. Mehta, S. Taneja, and A. Duseja. 2024. Metabolic dysfunction-associated steatotic liver disease (MASLD) definition is better than MAFLD criteria for lean patients with NAFLD. Journal of Hepatology 80(2):e61\u2013e62.","journal-title":"Journal of Hepatology"},{"issue":"4","key":"2489_CR3","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi, Z. M., P. Golabi, J. M. Paik, A. Henry, C. Van Dongen, and L. Henry. 2023. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology 77(4):1335\u20131347.","journal-title":"Hepatology"},{"issue":"1","key":"2489_CR4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41572-025-00599-1","volume":"11","author":"DQ Huang","year":"2025","unstructured":"Huang, D. Q., V. W. S. Wong, M. E. Rinella, J. Boursier, J. V. Lazarus, H. Yki-J\u00e4rvinen, and R. Loomba. 2025. Metabolic dysfunction-associated steatotic liver disease in adults. Nat Rev Dis Primers 11(1):14.","journal-title":"Nat Rev Dis Primers"},{"key":"2489_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25115640","author":"P Portincasa","year":"2024","unstructured":"Portincasa, P., M. Khalil, L. Mahdi, V. Perniola, V. Idone, A. Graziani, G. Baffy, and A. Di Ciaula. 2024. Metabolic dysfunction-associated steatotic liver disease: From pathogenesis to current therapeutic options. International Journal of Molecular Sciences 25(11):5640 https:\/\/doi.org\/10.3390\/ijms25115640.","journal-title":"International Journal of Molecular Sciences"},{"issue":"10390","key":"2489_CR6","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1016\/S0140-6736(23)00634-7","volume":"401","author":"O Verrastro","year":"2023","unstructured":"Verrastro, O., S. Panunzi, L. Castagneto-Gissey, A. De Gaetano, E. Lembo, E. Capristo, C. Guidone, G. Angelini, F. Pennestr\u00ec, and L. Sessa et al. 2023. Bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial. Lancet 401(10390):1786\u20131797.","journal-title":"Lancet"},{"key":"2489_CR7","doi-asserted-by":"publisher","first-page":"154455","DOI":"10.1016\/j.metabol.2020.154455","volume":"115","author":"DA Koutoukidis","year":"2021","unstructured":"Koutoukidis, D. A., C. Koshiaris, J. A. Henry, M. Noreik, E. Morris, I. Manoharan, K. Tudor, E. Bodenham, A. Dunnigan, and S. A. Jebb et al. 2021. The effect of the magnitude of weight loss on non-alcoholic fatty liver disease: A systematic review and meta-analysis. Metabolism 115:154455.","journal-title":"Metabolism"},{"issue":"2","key":"2489_CR8","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.livres.2025.01.001","volume":"9","author":"JYL Chiang","year":"2025","unstructured":"Chiang, J.Y.L. 2025. New drug therapies for metabolic dysfunction-associated steatohepatitis. Liver Research 9(2):94\u2013103.","journal-title":"Liver Research"},{"issue":"5","key":"2489_CR9","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.cmet.2024.03.011","volume":"36","author":"MA Tincopa","year":"2024","unstructured":"Tincopa, M. A., Q. M. Anstee, and R. Loomba. 2024. New and emerging treatments for metabolic dysfunction-associated steatohepatitis. Cell Metab 36(5):912\u2013926.","journal-title":"Cell Metab"},{"issue":"9","key":"2489_CR10","first-page":"802","volume":"12","author":"Y Hu","year":"2024","unstructured":"Hu, Y., C. Sun, Y. Chen, Y.D. Liu, and J.G. Fan. 2024. Pipeline of new drug treatment for Non-alcoholic Fatty Liver Disease\/Metabolic dysfunction-associated steatotic liver disease. Journal of Clinical and Translational Hepatology 12(9):802\u2013814.","journal-title":"Journal of Clinical and Translational Hepatology"},{"issue":"8","key":"2489_CR11","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41574-022-00675-6","volume":"18","author":"E Barreby","year":"2022","unstructured":"Barreby, E., P. Chen, and M. Aouadi. 2022. Macrophage functional diversity in NAFLD - more than inflammation. Nature Reviews. Endocrinology 18(8):461\u2013472.","journal-title":"Nature Reviews. Endocrinology"},{"issue":"10290","key":"2489_CR12","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell, E. E., V. W. Wong, and M. Rinella. 2021. Non-alcoholic fatty liver disease. Lancet 397(10290):2212\u20132224.","journal-title":"Lancet"},{"issue":"10","key":"2489_CR13","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41575-023-00807-x","volume":"20","author":"L Hammerich","year":"2023","unstructured":"Hammerich, L., and F. Tacke. 2023. Hepatic inflammatory responses in liver fibrosis. Nature Reviews. Gastroenterology & Hepatology 20(10):633\u2013646.","journal-title":"Nature Reviews. Gastroenterology & Hepatology"},{"issue":"8","key":"2489_CR14","doi-asserted-by":"publisher","first-page":"101414","DOI":"10.1016\/j.jhepr.2025.101414","volume":"7","author":"Y Kim","year":"2025","unstructured":"Kim, Y., Y. Park, H. Rho, T. Yao, B. Gao, and S. Hwang. 2025. Inflammation in MASLD progression and cancer. JHEP Rep 7(8):101414.","journal-title":"JHEP Rep"},{"key":"2489_CR15","doi-asserted-by":"publisher","first-page":"803037","DOI":"10.3389\/fimmu.2021.803037","volume":"12","author":"C Wang","year":"2021","unstructured":"Wang, C., C. Ma, L. Gong, Y. Guo, K. Fu, Y. Zhang, H. Zhou, and Y. Li. 2021. Macrophage polarization and its role in liver disease. Frontiers in Immunology 12: 803037.","journal-title":"Frontiers in Immunology"},{"issue":"3","key":"2489_CR16","doi-asserted-by":"publisher","first-page":"e0310","DOI":"10.1097\/HC9.0000000000000310","volume":"8","author":"Q Long","year":"2024","unstructured":"Long, Q., F. Luo, B. Li, Z. Li, Z. Guo, Z. Chen, W. Wu, and M. Hu. 2024. Gut microbiota and metabolic biomarkers in metabolic dysfunction-associated steatotic liver disease. Hepatol Commun 8(3):e0310.","journal-title":"Hepatol Commun"},{"issue":"11","key":"2489_CR17","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/j.cmet.2022.09.017","volume":"34","author":"H Tilg","year":"2022","unstructured":"Tilg, H., T. E. Adolph, and M. Trauner. 2022. Gut-liver axis: Pathophysiological concepts and clinical implications. Cell Metab 34(11):1700\u20131718.","journal-title":"Cell Metab"},{"key":"2489_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12091680","author":"M Zhu","year":"2023","unstructured":"Zhu, M., O.M.A. Dagah, B.B. Silaa, and J. Lu. 2023. Thioredoxin\/glutaredoxin systems and gut microbiota in NAFLD: Interplay, mechanism, and therapeutical potential. Antioxidants 12(9):1680. https:\/\/doi.org\/10.3390\/antiox12091680.","journal-title":"Antioxidants"},{"issue":"3","key":"2489_CR19","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","volume":"72","author":"A Albillos","year":"2020","unstructured":"Albillos, A., A. de Gottardi, and M. Rescigno. 2020. The gut-liver axis in liver disease: Pathophysiological basis for therapy. Journal Of Hepatology 72(3):558\u2013577.","journal-title":"Journal Of Hepatology"},{"key":"2489_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/metabo14070366","author":"NG Vallianou","year":"2024","unstructured":"Vallianou, N.G., D. Kounatidis, S. Psallida, N. Vythoulkas-Biotis, A. Adamou, T. Zachariadou, S. Kargioti, I. Karampela, and M. Dalamaga. 2024. NAFLD\/MASLD and the gut-liver axis: From pathogenesis to treatment options. Metabolites 14(7):366. https:\/\/doi.org\/10.3390\/metabo14070366.","journal-title":"Metabolites"},{"key":"2489_CR21","doi-asserted-by":"publisher","first-page":"1508060","DOI":"10.3389\/fphar.2024.1508060","volume":"15","author":"C Wang","year":"2024","unstructured":"Wang, C., X. Feng, W. Li, L. Chen, X. Wang, Y. Lan, R. Tang, T. Jiang, L. Zheng, and G. Liu. 2024. Apigenin as an emerging hepatoprotective agent: Current status and future perspectives. Frontiers in Pharmacology 15: 1508060.","journal-title":"Frontiers in Pharmacology"},{"key":"2489_CR22","doi-asserted-by":"publisher","first-page":"1574154","DOI":"10.3389\/fphar.2025.1574154","volume":"16","author":"C Chen","year":"2025","unstructured":"Chen, C., X. Bu, L. Deng, J. Xia, X. Wang, L. Chen, W. Li, J. Huang, Q. Chen, and C. Wang. 2025. Astragaloside IV as a promising therapeutic agent for liver diseases: Current landscape and future perspectives. Frontiers in Pharmacology 16: 1574154.","journal-title":"Frontiers in Pharmacology"},{"issue":"1","key":"2489_CR23","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s10753-025-02407-0","volume":"49","author":"L Chen","year":"2025","unstructured":"Chen, L., C. Chen, Q. Chen, T. Jiang, L. Zheng, R. Tang, and C. Wang. 2025. Deacetylasperulosidic acid methyl ester ameliorates carbon tetrachloride-induced liver fibrosis by suppressing inflammation and modulating gut microbiota. Inflammation 49(1):16.","journal-title":"Inflammation"},{"key":"2489_CR24","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S577265","author":"W Wen","year":"2026","unstructured":"Wen, W., J.Y. Xia, G. Liu, and C. Wang. 2026. Matrine in liver diseases: Mechanistic insights and therapeutic potential. Drug Design, Development and Therapy 20:1\u201330. https:\/\/doi.org\/10.2147\/DDDT.S577265.","journal-title":"Drug Design, Development and Therapy"},{"key":"2489_CR25","doi-asserted-by":"publisher","first-page":"110985","DOI":"10.1016\/j.biopha.2020.110985","volume":"133","author":"J Bai","year":"2021","unstructured":"Bai, J., Y. Zhang, C. Tang, Y. Hou, X. Ai, X. Chen, Y. Zhang, X. Wang, and X. Meng. 2021. Gallic acid: Pharmacological activities and molecular mechanisms involved in inflammation-related diseases. Biomedicine & Pharmacotherapy 133:110985.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"4","key":"2489_CR26","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1007\/s10787-023-01254-5","volume":"31","author":"PR Chougule","year":"2023","unstructured":"Chougule, P. R., R. Sangaraju, P. B. Patil, S. Qadri, V. V. Panpatil, S. Ghosh, S. K. Mungamuri, M. Bhanoori, and S. N. Sinha. 2023. Effect of ethyl gallate and propyl gallate on dextran sulfate sodium (DSS)-induced ulcerative colitis in C57BL\/6 J mice: preventive and protective. Inflammopharmacology 31(4):2103\u20132120.","journal-title":"Inflammopharmacology"},{"issue":"1","key":"2489_CR27","doi-asserted-by":"publisher","first-page":"e14369","DOI":"10.1111\/cbdd.14369","volume":"103","author":"D Ezhilarasan","year":"2024","unstructured":"Ezhilarasan, D., K. Shree Harini, M. Karthick, and C. Selvaraj. 2024. Ethyl gallate concurrent administration protects against acetaminophen-induced acute liver injury in mice: An in vivo and in silico approach. Chemical Biology & Drug Design 103(1):e14369.","journal-title":"Chemical Biology & Drug Design"},{"issue":"Pt B","key":"2489_CR28","doi-asserted-by":"publisher","first-page":"120442","DOI":"10.1016\/j.jep.2025.120442","volume":"353","author":"Q Zhang","year":"2025","unstructured":"Zhang, Q., H. Dai, C. Bu, Z. Gao, C. Hou, and S. Chen. 2025. Ethyl gallate isolated from Gypsophila licentiana Hand. -Mazz reduces the risk of liver injury by modulating the RAS pathway. Journal of Ethnopharmacology 353 (Pt B): 120442.","journal-title":"Journal of Ethnopharmacology"},{"issue":"3","key":"2489_CR29","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/s40203-025-00455-w","volume":"13","author":"G Nikrita, Choudhary","year":"2025","unstructured":"Nikrita, Choudhary, G., H. Kaur, A. Prakash, and B. Medhi. 2025. Computational discovery of Ethyl gallate as a novel toll-interacting-protein (TOLLIP) interactor: a therapeutic strategy against paraquat-induced toxicity. In Silico Pharmacol 13(3):176.","journal-title":"In Silico Pharmacol"},{"key":"2489_CR30","doi-asserted-by":"publisher","first-page":"150925","DOI":"10.1016\/j.bbrc.2024.150925","volume":"737","author":"K Nagori","year":"2024","unstructured":"Nagori, K., M. Pradhan, and K. T. Nakhate. 2024. Ethyl gallate ameliorates diabetes-induced Alzheimer\u2019s disease-like phenotype in rats via activation of \u03b17 nicotinic receptors and mitigation of oxidative stress. Biochemical And Biophysical Research Communications 737:150925.","journal-title":"Biochemical And Biophysical Research Communications"},{"key":"2489_CR31","doi-asserted-by":"publisher","DOI":"10.2174\/0115672026409563251204065841","author":"HD Pawar","year":"2026","unstructured":"Pawar, H. D., S. Chaudhari, P. G. Barote, K. T. Nakhate, and A. Sherikar. 2026. S NG: Ameliorative Potential of Ethyl Gallate in a Rat Model of Chronic Constriction Injury-Induced Neuropathic Pain. Current Neurovascular Res. https:\/\/doi.org\/10.2174\/0115672026409563251204065841","journal-title":"Current Neurovascular Research"},{"issue":"4","key":"2489_CR32","doi-asserted-by":"publisher","first-page":"e70133","DOI":"10.1002\/fsn3.70133","volume":"13","author":"P Leng","year":"2025","unstructured":"Leng, P., Y. Wang, and M. Xie. 2025. Ellagic Acid and Gut Microbiota: Interactions, and Implications for Health. Food Sci Nutr 13(4):e70133.","journal-title":"Food Sci Nutr"},{"issue":"1","key":"2489_CR33","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1080\/21623945.2015.1071454","volume":"5","author":"F Chiazza","year":"2016","unstructured":"Chiazza, F., T. D. Challa, F. C. Lucchini, D. Konrad, and S. Wueest. 2016. A short bout of HFD promotes long-lasting hepatic lipid accumulation. Adipocyte 5(1):88\u201392.","journal-title":"Adipocyte"},{"key":"2489_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/nu11123067","author":"L Recena Aydos","year":"2019","unstructured":"Recena Aydos, L., L. Aparecida do Amaral, R. de Serafim Souza, A.C. Jacobowski, E. Freitas Dos Santos, and M.L. Rodrigues Macedo. 2019. Nonalcoholic fatty liver disease induced by high-fat diet in C57bl\/6 models. Nutrients 11(12):3067. https:\/\/doi.org\/10.3390\/nu11123067.","journal-title":"Nutrients"},{"issue":"1","key":"2489_CR35","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10517-024-06275-w","volume":"178","author":"AA Zabolotneva","year":"2024","unstructured":"Zabolotneva, A. A., T. A. Laskina, D. N. Kharchev, and A. V. Shestopalov. 2024. Effects of a Short-Term High-Fat Diet on Microbiota Biodiversity of the Small and Large Intestines of C57BL\/6SPF Mice. Bulletin Of Experimental Biology And Medicine 178(1):17\u201323.","journal-title":"Bulletin Of Experimental Biology And Medicine"},{"key":"2489_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242316733","author":"X Zhu","year":"2023","unstructured":"Zhu, X., J. Cai, Y. Wang, X. Liu, X. Chen, H. Wang, Z. Wu, W. Bao, H. Fan, and S. Wu. 2023. A high-fat diet increases the characteristics of gut microbial composition and the intestinal damage associated with non-alcoholic fatty liver disease. International Journal of Molecular Sciences 24(23):16733. https:\/\/doi.org\/10.3390\/ijms242316733.","journal-title":"International Journal of Molecular Sciences"},{"key":"2489_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23095020","author":"D Ahn","year":"2022","unstructured":"Ahn, D., J. Kim, G. Nam, X. Zhao, J. Kwon, J.Y. Hwang, J.K. Kim, S.Y. Yoon, and S.J. Chung. 2022. Ethyl gallate dual-targeting PTPN6 and PPAR\u03b3 shows anti-diabetic and anti-obese effects. International Journal of Molecular Sciences 23(9):5020. https:\/\/doi.org\/10.3390\/ijms23095020.","journal-title":"International Journal of Molecular Sciences"},{"key":"2489_CR38","doi-asserted-by":"publisher","first-page":"114533","DOI":"10.1016\/j.jep.2021.114533","volume":"284","author":"Z Wang","year":"2022","unstructured":"Wang, Z., R. Xue, M. Lv, Y. Qi, W. Yu, Z. Xie, W. Chen, X. Wang, X. Tian, and B. Han. 2022. Stepwise tracking strategy to screen ingredient from Galla Chinensis based on the mass spectrometry guided preparative chromatography coupled with systems pharmacology. Journal Of Ethnopharmacology 284:114533.","journal-title":"Journal Of Ethnopharmacology"},{"key":"2489_CR39","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.physbeh.2019.01.014","volume":"204","author":"HS Appiakannan","year":"2019","unstructured":"Appiakannan, H. S., D. R. Kestyus, and E. T. Weber. 2019. Effects of high fat diet and chronic circadian challenge on glucocorticoid regulation in C57BL\/6J mice. Physiology & Behavior 204:100\u2013105.","journal-title":"Physiology & Behavior"},{"key":"2489_CR40","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.sleep.2024.02.044","volume":"117","author":"D Zhao","year":"2024","unstructured":"Zhao, D., X. Wang, H. Liu, M. Su, M. Sun, L. Zhang, and H. Ye. 2024. Effect of circadian rhythm change on gut microbiota and the development of nonalcoholic fatty liver disease in mice. Sleep Medicine 117:131\u2013138.","journal-title":"Sleep Medicine"},{"key":"2489_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/cells14060463","author":"MAA Mamun","year":"2025","unstructured":"Mamun, M.A.A., A. Rakib, M. Mandal, and U.P. Singh. 2025. Impact of a high-fat diet on the gut microbiome: A comprehensive study of microbial and metabolite shifts during obesity. Cells 14(6):463. https:\/\/doi.org\/10.3390\/cells14060463.","journal-title":"Cells"},{"key":"2489_CR42","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1146\/annurev-physiol-031522-092054","volume":"85","author":"BK Perler","year":"2023","unstructured":"Perler, B. K., E. S. Friedman, and G. D. Wu. 2023. The Role of the Gut Microbiota in the Relationship Between Diet and Human Health. Annual Review Of Physiology 85:449\u2013468.","journal-title":"Annual Review Of Physiology"},{"issue":"16","key":"2489_CR43","doi-asserted-by":"publisher","first-page":"4137","DOI":"10.1016\/j.cell.2021.06.019","volume":"184","author":"HC Wastyk","year":"2021","unstructured":"Wastyk, H. C., G. K. Fragiadakis, D. Perelman, D. Dahan, B. D. Merrill, F. B. Yu, M. Topf, C. G. Gonzalez, W. Van Treuren, and S. Han et al. 2021. Gut-microbiota-targeted diets modulate human immune status. Cell 184(16):4137\u20134153e4114.","journal-title":"Cell"},{"key":"2489_CR44","doi-asserted-by":"publisher","first-page":"177827","DOI":"10.1016\/j.ejphar.2025.177827","volume":"1002","author":"R Wang","year":"2025","unstructured":"Wang, R., Z. Lin, M. He, Y. Liao, Y. Xu, C. Chen, X. Duan, X. Jiang, and J. Qiu. 2025. The role of gut microbiota in Tirzepatide-mediated alleviation of high-fat diet-induced obesity. European Journal of Pharmacology 1002:177827.","journal-title":"European Journal of Pharmacology"},{"issue":"8","key":"2489_CR45","doi-asserted-by":"publisher","first-page":"5762","DOI":"10.1002\/fsn3.4208","volume":"12","author":"W Gao","year":"2024","unstructured":"Gao, W., X. Chen, S. Wu, L. Jin, X. Chen, G. Mao, X. Wan, and W. Xing. 2024. Monascus red pigments alleviate high-fat and high-sugar diet-induced NAFLD in mice by modulating the gut microbiota and metabolites. Food Science & Nutrition 12(8):5762\u20135775.","journal-title":"Food Science & Nutrition"},{"key":"2489_CR46","doi-asserted-by":"publisher","first-page":"1161698","DOI":"10.3389\/fnut.2023.1161698","volume":"10","author":"X Zhou","year":"2023","unstructured":"Zhou, X., L. Ma, L. Dong, D. Li, F. Chen, and X. Hu. 2023. Bamboo shoot dietary fiber alleviates gut microbiota dysbiosis and modulates liver fatty acid metabolism in mice with high-fat diet-induced obesity. Front Nutr 10:1161698.","journal-title":"Front Nutr"},{"issue":"5","key":"2489_CR47","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1039\/D1FO03147C","volume":"13","author":"Y Lan","year":"2022","unstructured":"Lan, Y., Q. Sun, Z. Ma, J. Peng, M. Zhang, C. Wang, X. Zhang, X. Yan, L. Chang, and X. Hou et al. 2022. Seabuckthorn polysaccharide ameliorates high-fat diet-induced obesity by gut microbiota-SCFAs-liver axis. Food & Function 13(5):2925\u20132937.","journal-title":"Food & Function"},{"key":"2489_CR48","doi-asserted-by":"publisher","first-page":"127648","DOI":"10.1016\/j.micres.2024.127648","volume":"282","author":"Z Chuandong","year":"2024","unstructured":"Chuandong, Z., J. Hu, J. Li, Y. Wu, C. Wu, G. Lai, H. Shen, F. Wu, C. Tao, S. Liu, et al. 2024. Distribution and roles of Ligilactobacillus murinus in hosts. Microbiological Research 282:127648.","journal-title":"Microbiological Research"},{"issue":"23","key":"2489_CR49","doi-asserted-by":"publisher","first-page":"10549","DOI":"10.1039\/D3FO03867J","volume":"14","author":"S Yan","year":"2023","unstructured":"Yan, S., L. Yu, F. Tian, J. Zhao, W. Chen, H. Chen, and Q. Zhai. 2023. Ligilactobacillus salivarius CCFM 1266 modulates gut microbiota and GPR109a-mediated immune suppression to attenuate immune checkpoint blockade-induced colitis. Food & Function 14(23):10549\u201310563.","journal-title":"Food & Function"},{"key":"2489_CR50","doi-asserted-by":"publisher","first-page":"151033","DOI":"10.1016\/j.bbrc.2024.151033","volume":"741","author":"X Xu","year":"2024","unstructured":"Xu, X., Y. Wang, X. Wu, T. Cai, L. Dong, S. Liang, L. Zhu, X. Song, Y. Dong, Y. Zheng, et al. 2024. Administration of Alistipes indistinctus prevented the progression from nonalcoholic fatty liver disease to nonalcoholic steatohepatitis by enhancing the gut barrier and increasing Lactobacillus spp. Biochemical and Biophysical Research Communications 741:151033.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"2489_CR51","doi-asserted-by":"publisher","first-page":"1105405","DOI":"10.3389\/fphar.2023.1105405","volume":"14","author":"L Wang","year":"2023","unstructured":"Wang, L., X. Gou, Y. Ding, J. Liu, Y. Wang, Y. Wang, J. Zhang, L. Du, W. Peng, and G. Fan. 2023. The interplay between herbal medicines and gut microbiota in metabolic diseases. Frontiers In Pharmacology 14:1105405.","journal-title":"Frontiers In Pharmacology"},{"issue":"2","key":"2489_CR52","first-page":"452","volume":"11","author":"L Liu","year":"2023","unstructured":"Liu, L., M. Yin, J. Gao, C. Yu, J. Lin, A. Wu, J. Zhu, C. Xu, and X. Liu. 2023. Intestinal barrier function in the pathogenesis of nonalcoholic fatty liver disease. Journal of Clinical and Translational Hepatology 11(2):452\u2013458.","journal-title":"Journal of Clinical and Translational Hepatology"},{"issue":"1","key":"2489_CR53","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/ptr.8027","volume":"38","author":"X Wang","year":"2024","unstructured":"Wang, X., X. Xie, Y. Li, X. Xie, S. Huang, S. Pan, Y. Zou, Z. Pan, Q. Wang, and J. Chen et al. 2024. Quercetin ameliorates ulcerative colitis by activating aryl hydrocarbon receptor to improve intestinal barrier integrity. Phytotherapy Research: Ptr 38(1):253\u2013264.","journal-title":"Phytotherapy Research: Ptr"},{"issue":"2","key":"2489_CR54","doi-asserted-by":"publisher","first-page":"e1193","DOI":"10.1002\/iid3.1193","volume":"12","author":"X Yu","year":"2024","unstructured":"Yu, X., Y. Wang, Y. Xu, X. Li, J. Zhang, Y. Su, and L. Guo. 2024. Resveratrol attenuates intestinal epithelial barrier dysfunction via Nrf2\/HO-1 pathway in dextran sulfate sodium-induced Caco-2 cells. Immunity, Inflammation And Disease 12(2):e1193.","journal-title":"Immunity, Inflammation And Disease"},{"key":"2489_CR55","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.bbrc.2021.03.158","volume":"556","author":"W Liu","year":"2021","unstructured":"Liu, W., J. Liu, S. Xing, X. Pan, S. Wei, M. Zhou, Z. Li, L. Wang, and J. K. Bielicki. 2021. The benzoate plant metabolite ethyl gallate prevents cellular- and vascular-lipid accumulation in experimental models of atherosclerosis. Biochemical And Biophysical Research Communications 556:65\u201371.","journal-title":"Biochemical And Biophysical Research Communications"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-026-02489-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-026-02489-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-026-02489-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T16:02:19Z","timestamp":1775577739000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-026-02489-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2489"],"URL":"https:\/\/doi.org\/10.1007\/s10753-026-02489-4","relation":{},"ISSN":["1573-2576"],"issn-type":[{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]},"assertion":[{"value":"15 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures were conducted in accordance with the Guidelines for the Care and Use of Laboratory Animals of Shandong Second Medical University and were approved by the Institutional Animal Care and Use Committee of the same institution (Approval No. 2025SDL613).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All authors have read the manuscript and authorized its publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Number"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"132"}}